ResearcherTohoku UniversityActive in the last 2 years
Shingo Yoshimachi
Matched on ORCID iD 0000-0002-8823-6696; OpenAlex author ID A5059519894. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 5
- SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancreatic cancer. Co-author DOI 10.1016/j.pan.2026.03.007↗
- Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Preceding Neoadjuvant Therapy for Pancreatic Duc… Co-author DOI 10.1097/mpa.0000000000002503↗
- Ral GTPase promotes metastasis of pancreatic ductal adenocarcinoma via elevation of TGF-β1 production. Co-author DOI 10.1016/j.jbc.2023.104754↗
- Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/cas.14970↗
- Prognostic impact of intraoperative peritoneal cytology after neoadjuvant therapy for potentially resectable pancreatic cancer. Co-author DOI 10.1016/j.pan.2020.08.022↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michiaki Unno · 5 shared papers, 2020–2026 · strength 0.81
- Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
- Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
- Paper Ral GTPase promotes metastasis of pancreatic ductal adenocarcinoma via elevation of TGF-β1 production. DOI 10.1016/j.jbc.2023.104754↗
- Shimpei Maeda · 4 shared papers, 2020–2026 · strength 0.64
- Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
- Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
- Paper Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma. DOI 10.1111/cas.14970↗
- Masamichi Mizuma · 3 shared papers, 2020–2026 · strength 0.53
- Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
- Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
- Paper Prognostic impact of intraoperative peritoneal cytology after neoadjuvant therapy for potentially resectable pancreatic… DOI 10.1016/j.pan.2020.08.022↗
- Shuichi Aoki · 3 shared papers, 2020–2026 · strength 0.53
- Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
- Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
- Paper Prognostic impact of intraoperative peritoneal cytology after neoadjuvant therapy for potentially resectable pancreatic… DOI 10.1016/j.pan.2020.08.022↗
- Mitsuhiro Shimura · 2 shared papers, 2025–2026 · strength 0.44
- Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
- Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
- Masahiro Iseki · 2 shared papers, 2025–2026 · strength 0.44
- Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
- Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
- Daisuke Douchi · 2 shared papers, 2025–2026 · strength 0.44
- Paper SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancr… DOI 10.1016/j.pan.2026.03.007↗
- Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
- Fuyuhiko Motoi · 2 shared papers, 2020–2025 · strength 0.29
- Paper Local Recurrence and Survival Outcomes after Portal Vein/Superior Mesenteric Vein Separation without Resection Precedin… DOI 10.1097/mpa.0000000000002503↗
- Paper Prognostic impact of intraoperative peritoneal cytology after neoadjuvant therapy for potentially resectable pancreatic… DOI 10.1016/j.pan.2020.08.022↗
- Ming‐xin Cao · 2 shared papers, 2021–2023 · strength 0.27
- Hisanori Horiuchi · 2 shared papers, 2021–2023 · strength 0.27
- Naohiro Hirano · 1 shared paper, 2026 · strength 0.24
- Atsushi Masamune · 1 shared paper, 2026 · strength 0.24
- Kyohei Ariake · 2 shared papers, 2020–2021 · strength 0.20
- Koetsu Inoue · 1 shared paper, 2025 · strength 0.20
- Aya Noguchi · 1 shared paper, 2025 · strength 0.20
- Kento Miyazaki · 1 shared paper, 2021 · strength 0.11
- Kei Kawaguchi · 1 shared paper, 2020 · strength 0.09
- Tatsuo Hata · 1 shared paper, 2020 · strength 0.09
- Tatsuyuki Takadate · 1 shared paper, 2020 · strength 0.09
- Kei Nakagawa · 1 shared paper, 2020 · strength 0.09
- Takanori Morikawa · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.